Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering f…
$4.64-3.44%
报价 2026-11-16
市值
$7.3M
EV
$6.5M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -56.2%
$3.66$10.58
筛选结果
pipeline · 2026-11-16Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CURXCuranex Pharmaceuticals Inc Common Stock | $7.3M | -3.4% | – | 0% | – | – | – | |
| PALIPalisade Bio, Inc. | $184.7M | -8.0% | +130.6% | 0% | – | – | – | |
| BCTXBriaCell Therapeutics Corp. | $28.8M | -2.7% | – | 0% | – | – | – | |
| DAREDaré Bioscience, Inc. | $8.8M | -11.1% | -62.5% | 30,089.1% | – | – | – | |
| LGVNLongeveron Inc. | $6.5M | -14.1% | +11.1% | 69.8% | – | – | – | |
| PULMPulmatrix, Inc. | $4.7M | -0.8% | +135.7% | 0% | – | – | – | |
| CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares | $4.5M | -0.6% | – | -1.3% | – | – | – | |
| ASBPAspire Biopharma Holdings, Inc. | $929,898 | -4.2% | – | 18.4% | – | – | – | |
| CRISCuris, Inc. | $849,810 | -2.1% | -84.3% | 99.3% | – | – | – | |
| 同行中位数 | – | – | +11.1% | 9.2% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。